If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Posting of 2021 Annual Report & Accounts

25 May 2022 07:00

RNS Number : 6750M
Surgical Innovations Group PLC
25 May 2022
 

 

Surgical Innovations Group plc

("Surgical Innovations", "SI" or the "Company")

 

Posting of 2021 Annual Report & Accounts

Notice of Annual General Meeting

 

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), confirms that the Annual Report and Accounts for the year ended 31 December 2021 ("2021 Annual Report") and the Notice of the 2022 Annual General Meeting ("AGM") have now been published and can be accessed via the "Investor Centre" section of the Company's website at: www.sigroupplc.com

 

The 2021 Annual Report, the Notice of AGM and details voting by proxy will be posted to shareholders who have not consented to receive electronic communications.

 

Notice of AGM

The AGM is to be held on Monday 27 June 2022 at 10:00 am at the Company's offices at Clayton Wood House, 6 Clayton Wood Bank, Leeds, LS16 6QZ and will consider the Resolutions set out in the Notice of AGM.

 

We encourage shareholders to participate in the AGM by voting by proxy. As it is not always possible to attend and ask questions in person, we will provide an opportunity for shareholder engagement prior to the AGM. In order to facilitate this, if you are a shareholder and would like to ask the Board a question, please submit your questions to the following email: si@surginno.co.uk, titled 'AGM'. Shareholders should note that any questions in relation to confidential or potentially price sensitive matters cannot be addressed.

 

The proxy appointment form should be returned, or the electronic proxy appointment instruction transmitted, no later than 10:00 am on Thursday 23 June 2022. More details can be found in the Notice of AGM.

 

 

 

For further information please contact:

 

 

Surgical Innovations Group plc

www sigroupplc com

David Marsh, CEO

Tel: 0113 230 7597

Charmaine Day, CFO

 

 

 

Singer Capital Markets (Nominated Adviser & Broker)

Tel: 020 7496 3000

Aubrey Powell / Rachel Hayes

 

 

 

Walbrook PR (Financial PR & Investor Relations)

Tel: 020 7933 8780 or si@walbrookpr.com

Paul McManus / Lianne Applegarth

Mob: 07980 541 893 / 07584 391 303

 

About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of innovative, high quality medical products, primarily for use in minimally invasive surgery. Our product and business development is guided and supported by a key group of nationally and internationally renowned surgeons across the spectrum of minimally invasive surgical activity.

 

We design and manufacture and source our branded port access systems, surgical instruments and retraction devices which are sold directly in the UK home market through our subsidiary, Elemental Healthcare, and exported widely through a global network of trusted distribution partners. Many of our products in this field are based on a "resposable" concept, in which the products are part reusable, part disposable, offering a high quality and environmentally responsible solution at a cost that is competitive against fully disposable alternatives.

 

Elemental also has exclusive UK distribution for a select group of specialist products employed in laparoscopy, bariatric and metabolic surgery, hernia repair and breast reconstruction.

 

In addition, we design and develop medical devices for carefully selected OEM partners and have also collaborated with a major UK industrial partner to provide precision engineering solutions to complex problems outside the medical arena.

 

We aim for our brands to be recognised and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership or acquisition a broad portfolio of cost effective, procedure specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs in the operating theatre environment.

 

Further information

Further details of the Group's businesses and products are available on the following websites:

www.sigroupplc.com

www.surginno.com

www.elementalhealthcare.co.uk

 

To receive regular updates by email, please contact si@walbrookpr.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAIMRTMTMTBFT
Date   Source Headline
4th Jun 201811:34 amRNSHolding(s) in Company
25th May 20187:00 amRNSTrading Update
23rd Mar 20183:25 pmRNSDirector/PDMR Shareholding
13th Mar 20183:06 pmRNSDirector/PDMR Shareholding
13th Mar 20187:00 amRNSFinal Results
28th Feb 20187:00 amRNSDistribution agreement via Elemental Healthcare
19th Feb 20187:01 amRNSDistribution agreement via Elemental Healthcare
19th Feb 20187:00 amRNSNotice of Results
11th Jan 20187:00 amRNSYear-end trading update
21st Dec 201712:15 pmRNSIssue of Shares
15th Nov 201711:47 amRNSDirector/PDMR Shareholding
6th Nov 20177:00 amRNSDirector/PDMR Shareholding
31st Oct 201710:58 amRNSDirector/PDMR Shareholding
31st Oct 20177:00 amRNSGrant of Options
30th Oct 20172:33 pmRNSIssue of Equity
10th Oct 20173:36 pmRNSIssue of Equity
26th Sep 201712:28 pmRNSIssue of Equity
22nd Sep 20178:55 amRNSHolding(s) in Company
13th Sep 20177:00 amRNSHalf-year Report
10th Aug 20177:00 amRNSNotice of Results
4th Aug 201712:32 pmRNSNotification of Major Interest in Shares
3rd Aug 20179:30 amRNSNotification of Major Interest in Shares
2nd Aug 20171:31 pmRNSNotification of Major Interest in Shares
1st Aug 20174:48 pmRNSNotification of Major Interest in Shares
1st Aug 20178:07 amRNSAcquisition, PDMR Dealings and Directorate Changes
28th Jul 20177:00 amRNSDirector/PDMR Shareholdings
27th Jul 201710:53 amRNSResult of Equity Issue
27th Jul 20177:00 amRNSProposed Acquisition, Placing and Subscriptions
30th Jun 20175:07 pmRNSHolding(s) in Company
30th Jun 20175:05 pmRNSHolding(s) in Company
26th Jun 20172:40 pmRNSResult of AGM
26th Jun 201710:45 amRNSIssue of Shares
26th Jun 20177:00 amRNSAGM Statement
5th Jun 20174:24 pmRNSAnnual Report & Accounts and Notice of AGM
11th Apr 20179:03 amRNSDirector/PDMR Shareholding
3rd Apr 201711:26 amRNSDirector/PDMR Shareholding
28th Mar 20177:00 amRNSDirector/PDMR Shareholding
27th Mar 20177:00 amRNSIssue of Shares
14th Mar 20177:00 amRNSFinal Results
1st Mar 20177:00 amRNSNotice of Results
9th Jan 20177:00 amRNSYear-end trading update
22nd Dec 20167:00 amRNSRevised Banking Facilities
21st Dec 20167:00 amRNSConversion of Loan Notes & Issue of Shares
20th Dec 20167:00 amRNSDirector's responsibilities
21st Nov 20167:00 amRNSSite visit
7th Nov 20167:00 amRNSAcquisition
2nd Nov 20161:40 pmRNSDirector/PDMR Shareholding
26th Oct 20167:00 amRNSCE Certification for YelloPort Elite®
30th Sep 20167:00 amRNSIssue of Shares
31st Aug 20167:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.